Aurora makes breakthrough low-temperature sterilizers for sensitive medical devices.

The sterilant is made of pure air gases, turned into plasmas (= northern lights). This technology paves the way to:
– the sterile reprocessing of complex medical devices in hospitals: GI endoscopes and echo-endoscopic probes
– environmentally friendly sterilization of medical devices manufactured by large medtech manufacturers

The company has been largely recognized for its unique technology and potential, as a France 2030 AMI-MIE, EIC Accelerator, and IPCEI Tech4Cure laureate.

Aurora’s first sales highlight strong market traction, and the company expects even stronger momentum with CE marking expected in Q4 2026 and FDA approval by the end of 2026. This is why Aurora is aiming to raise capital by the end of this year to support its growth.